开发一种简短的认知查工具,用于预测帕金森病患者手术后 Delirium:二次分析
Yongde Zhou1, Xiaoxiao Wang2,3, Zhengqian Li2,4
1Department of Anesthesiology, Tsinghua University Yuquan Hospital, Beijing, 100040, People's Republic of China.
Clinical interventions in aging
|September 20, 2023
概括
缩短的认知测试,迷你心理状态检查 (MMSE) 和蒙特利尔认知评估 (MoCA),有效地预测帕金森病患者的手术后妄 (POD). 这些快速评估适用于繁忙的手术前环境.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 医学诊断 医学诊断 医学诊断
背景情况:
- 需要在资源有限,快节奏的手术前环境中进行快速认知查测试.
- 接受手术的帕金森病 (PD) 患者有患术后妄想症 (POD) 的风险.
研究的目的:
- 开发和验证小型心理状态检查 (MMSE) 和蒙特利尔认知评估 (MoCA) 的缩写版本.
- 评估这些简短的认知测试在预测计划进行手术的PD患者中POD的有用性.
主要方法:
- 对128名PD住院患者进行的二次分析,这些患者接受了亚thalamic核深度大脑刺激 (STN-DBS).
- 使用MMSE和MoCA进行手术前认知查;通过混评估方法评估POD.
- 使用了后勤回归和接收器操作特征 (ROC) 曲线分析 (DeLong测试).
主要成果:
- 在128名PD患者中,有27名 (21.6%) 患有POD.
- 减少的MMSE显示出与原始MMSE (p=0.412) 相似的POD预测性能.
- 简短的MoCA显示了ROC曲线下的高面积 (AUC=0.826),与原来的MoCA (AUC=0.808,p=0.575) 相比.
结论:
- 简化的MMSE和MoCA版本可以有效地识别患有POD风险的PD患者.
- 简短的认知查测试对于在时间有限的手术前环境中预测POD是有价值的.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.9K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
相关概念视频
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
